Plant beneficial bacteria are microorganisms that form symbiotic relationships with plants, conferring various advantages to their host plants. These bacteria contribute to plant growth, development, and overall health through mechanisms such as nutrient fixation, disease suppression, and stress tolerance. Rhizobacteria, such as those in the genera Azospirillum and Pseudomonas, can enhance plant growth by promoting nutrient availability and stimulating root development. Nitrogen-fixing bacteria, like Rhizobium and Bradyrhizobium, form symbiotic associations with leguminous plants, converting atmospheric nitrogen into a usable form for the plants. Plant-growth-promoting rhizobacteria (PGPR) can also protect plants from pathogens by producing antimicrobial compounds and inducing systemic resistance. Additionally, some beneficial bacteria facilitate the absorption of nutrients like phosphorus and enhance the plant's ability to withstand environmental stresses. Harnessing the potential of plant beneficial bacteria has become a sustainable approach in agriculture, promoting eco-friendly practices and reducing the reliance on chemical inputs. Research continues to explore the diversity of beneficial bacteria, their interactions with plants, and ways to optimize their use for improving crop productivity and sustainability.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom